New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2014
10:01 EDTAMRE, EGAS, HW, AAP, TKMROn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AmREIT (AMRE) initiated with a Buy at SunTrust... Gas Natural (EGAS) initiated with a Hold at Wunderlich... Headwaters (HW) initiated with a Buy at Deutsche Bank... Advance Auto Parts (AAP) resumed with an Overweight at JPMorgan... Tekmira (TKMR) initiated with a Buy at Stifel.
News For AMRE;EGAS;HW;AAP;TKMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 17, 2014
14:50 EDTTKMRBARDA asks labs to ramp up Zmapp production, Reuters says
Subscribe for More Information
09:46 EDTTKMRSarepta soars after publication of Ebola drug candidate data
Subscribe for More Information
October 15, 2014
15:34 EDTTKMRTekmira TKM-HBN preclinical study shows 'knockdown of HBV surface antigen'
Subscribe for More Information
10:49 EDTTKMREbola linked names rise again amid broader market sell-off
Subscribe for More Information
09:57 EDTTKMRLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
08:58 EDTTKMRTekmira volatility up, 2nd Texas health-care worker tests positive for Ebola
Subscribe for More Information
October 14, 2014
16:39 EDTEGASBlack Hills acquires Gas Natural subsidiary for $17M
Subscribe for More Information
16:07 EDTEGASGas Natural announces sale of Wyoming assets for $17M
Gas Natural (EGAS) announced that its subsidiary, Energy West Incorporated, has signed a definitive agreement for the sale of its subsidiary, Energy West Wyoming, Inc., as well its Wyoming pipeline assets and related real estate, equipment and contracts to Black Hills Corporation (BKH) for $17M. The closing is subject to customary closing conditions, as well as regulatory approvals. The Energy West Wyoming transaction also contains a working capital adjustment at closing and a post-closing working capital "true-up." As part of the agreement, Energy West Incorporated and Black Hills Corporation will enter into a Transition Services Agreement to insure a seamless transition for Energy West Wyoming, Inc.'s Wyoming customers. The transaction is expected to close in approximately six to twelve months. Energy West Incorporated intends to use the proceeds from this transaction to reinvest into the business to generate solid returns on its invested capital. Including the gain anticipated on this transaction, the redeployment of resources is expected to have a significant positive impact on the company's earnings in 2015 and beyond.
11:19 EDTTKMRNIH says several potential Ebola treatments under development
Subscribe for More Information
10:10 EDTTKMRNIH director says supporting BioCryst, Chimerix Ebola treatments
Subscribe for More Information
09:04 EDTTKMRChinese company says drug can cure Ebola, Reuters reports
Subscribe for More Information
07:59 EDTHWHeadwaters management to meet with Deutsche Bank
Meetings to be held in San Francisco/Los Angeles on October 14 hosted by Deutsche Bank.
05:40 EDTTKMRTekmira partner Alnylam reports positive clinical data for Patisiran study
Tekmira Pharmaceuticals (TKMR) reported that Alnylam Pharmaceuticals (ALNY) presented six-month clinical data for the ongoing Patisiran Phase II Open Label Extension, or OLE, study in patients with Familial Amyloidotic Polyneuropathy, or FAP. Patisiran is an RNAi therapeutic targeting transthyretin, or TTR, in development for the treatment of TTR-mediated amyloidosis, or ATTR, which is enabled by Tekmira's lipid nanoparticle, or LNP, technology. Alnylam presented data at the American Neurological Association's 2014 Annual Meeting. Results showed a mean 0.95 point decrease in modified Neuropathy Impairment Score at six months in 19 patients with mNIS+7 data available for the current analysis. This decrease in neuropathy progression compares favorably with the 7 to 10 point increase in mNIS+7 at six months that can be estimated from historical data sets in untreated FAP patients with similar baseline characteristics.
October 13, 2014
07:12 EDTTKMROligonucleotide Therapeutics Society to hold annual meeting
Subscribe for More Information
07:11 EDTTKMRTekmira volatility elevated, Texas health-care worker tests positive for Ebola
Subscribe for More Information
October 12, 2014
19:26 EDTTKMRPatient being evaluated at Boston hospital for possible Ebola, Boston Globe says
Health officials say that a man that recently traveled to Liberia is being assessed at Beth Israel Deaconess hospital in Boston for the Ebola virus, the Boston Globe says. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
19:12 EDTTKMRCDC confirms Texas healthcare worker positive for Ebola
Subscribe for More Information
14:18 EDTTKMRNY's JFK Airport begins Ebola screenings, WSJ says
Subscribe for More Information
12:48 EDTTKMRTexas health-care worker tests positive for Ebola, WSJ says
Subscribe for More Information
October 10, 2014
10:54 EDTTKMRMapp looking to up production of experimental Ebola treatment, WSJ says
Mapp Biopharmaceutical is aiming to broaden the manufacturing of its experimental Ebola treatment, ZMapp, according to The Wall Street Journal, citing comments from the company. Mapp said that the treatment was given to a few infected individuals prior to supplies running out two months ago. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use